Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Aprea Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q1 2025
- Shares held
- 1.82M
- −134.2K (−6.9%) vs. Q1 2025
- Total value
- $3.07M
- −$711.0K (−18.8%) vs. Q1 2025
- New holders
- 1
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 539,300 | $913.0K | 0.43% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 279,369 | $472.1K | 0.19% | +2,766+1.0% | Added |
| Sphera Funds Management Ltd. | 270,000 | $456.3K | 0.12% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 205,760 | $347.7K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 173,842 | $295.5K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 137,174 | $231.8K | 0.06% | 00.0% | Unchanged |
| Morgan Stanley | 63,331 | $107.0K | 0.00% | +30,523+93.0% | Added |
| Geode Capital Management, LLC | 43,137 | $73.3K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 23,969 | $40.5K | 0.00% | −6,909−22.4% | Reduced |
| LPL Financial LLC | 17,052 | $28.8K | 0.00% | +1,000+6.2% | Added |
| BNP Paribas Arbitrage, SA | 15,432 | $26.2K | 0.00% | +1,721+12.6% | Added |
| Dimensional Fund Advisors LP | 14,465 | $24.6K | 0.00% | −2,190−13.1% | Reduced |
| HighTower Advisors, LLC | 13,864 | $23.4K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 8,504 | $14.4K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,856 | $8.21K | 0.00% | +4+0.1% | Added |
| Tower Research Capital LLC (TRC) | 2,963 | $5.01K | 0.00% | −363−10.9% | Reduced |
| MB, Levis & Associates, LLC | 806 | $1.36K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 577 | $981 | 0.00% | −247−30.0% | Reduced |
| FMR LLC | 501 | $852 | 0.00% | +501 | New |
| Advisor Group Holdings, Inc. | 400 | $676 | 0.00% | +300+300.0% | Added |
| WealthCollab, LLC | 158 | $268 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 40 | $68 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 8 | $13 | 0.00% | +5+166.7% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −30,083−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −28,972−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −102,242−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |